New York Medical College in Valhalla has been awarded $586,314 for research into heart and vascular disease. The funding was awarded through the U.S. Department of Health and Human Services’ National Heart, Lung and Blood Institute.
“Advances in scientific research hold tremendous potential to help the millions of people struggling with heart and metabolic problems,” said U.S. Rep. Nita Lowey, who announced the grant. “This funding will support New York Medical College’s cutting-edge research and innovation that may save lives.”
“I am truly excited to embark on these studies,” said Dr. Michal Laniado Schwartzman, professor and chair of the college’s department of pharmacology. Schwartzman is involved in research that might lead to new treatments for such diseases as heart failure, stroke and diabetes.